Back to Search

DAVID CARBONE, MD, PHD

MD, PHD

Medical Oncology Physician

NPI: 1558453977IndividualAccepts Medicare

Specialties, Licenses & Credentials

Hematology & Oncology Physician

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

35.120481(OH)
Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

35.120481(OH)

CMS Specialties

PrimaryMEDICAL ONCOLOGY

Education

JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE

Class of 1985

Research & Publications (20)

Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nitric-oxide synthase 2 expression in astrocytes by a novel diindolylmethane analog protects striatal neurons against apoptosis.
PMID 18840677·Mol Pharmacol·2009
7-preclinical
Profiles in variation: lung carcinogenesis.
PMID 19638487·Cancer Prev Res (Phila)·2009
8-other
Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
PMID 19493905·Carcinogenesis·2009
7-preclinical
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.
PMID 19404214·J Thorac Oncol·2009
3-trial
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer.
PMID 19276291·Clin Cancer Res·2009
3-trial
X-ray structure analysis of free-standing lipid membranes facilitated by micromachined apertures.
PMID 18370435·Langmuir·2008
8-other
Nuclear factor kappa-B mediates selective induction of neuronal nitric oxide synthase in astrocytes during low-level inflammatory stimulation with MPTP.
PMID 18508038·Brain Res·2008
7-preclinical
Versatile vacuum chamber for in situ surface X-ray scattering studies.
PMID 18552436·J Synchrotron Radiat·2008
8-other
Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomas.
PMID 18566219·Mol Cancer Ther·2008
7-preclinical
In vitro and in silico characterization of peroxiredoxin 6 modified by 4-hydroxynonenal and 4-oxononenal.
PMID 19548352·Chem Res Toxicol·2008
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
300 W 10TH AVE
COLUMBUS, OH 43210

Quick Facts

NPI
1558453977
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
41
Publications
20

Are you this provider?

Claim Your Profile